Literature DB >> 22782139

Respiratory therapy organizational changes are associated with increased respiratory care utilization.

Ann M Parker1, Xinggang Liu, Anthony D Harris, Carl B Shanholtz, Robin L Smith, Dean R Hess, Marty Reynolds, Giora Netzer.   

Abstract

BACKGROUND: The effect of the respiratory therapist (RT)/patient ratio and RT organizational factors on respiratory resource utilization is unknown. We describe the impact of a multi-component intervention that called for an increase in RT/patient ratio (1:14 to 1:10), improved RT orientation, and formation of a core staffing model on best practice, including spontaneous breathing trials (SBTs) and catheter and bronchoscopically directed lower respiratory tract cultures, or bronchoalveolar lavage (BAL), in both ventilated and non-ventilated patients in the ICU.
METHODS: We conducted a single center, quasi-experimental study comparing 651 patients with single and first admissions between April 19, 2005 and April 18, 2006 before the RT services reorganization with 1,073 patients with single and first admissions between September 16, 2007 and September 4, 2008. Baseline characteristics were compared, along with SBTs, BAL use, lower respiratory tract cultures, and chest physiotherapy.
RESULTS: Patients in the 2 groups were similar in terms of age (52.9 ± 15.8 y vs 53.9 ± 16.4 y, P = .23), comorbidity as measured by Charlson score (2.8 ± 2.6 vs 2.8 ± 2.7, P = .56), and acuity of illness as measured by the Case Mix Index (3.2 ± 3.9 vs 3.3 ± 4.1, P = .47). Mechanically ventilated patients had similar prevalences of respiratory diseases (24.2% vs 25.1%, P = .61). There was an increase in SBTs (0.5% vs 73.1%, P < .001), chest physiotherapy (7.4% vs 21.6%, P < .001), BALs (24.0% vs 41.4%, P < .001), and lower respiratory tract cultures (21.5% vs 38.0%, P < .001) in mechanically ventilated patients post-intervention.
CONCLUSIONS: A multi-component intervention, including an increase in RT/patient ratio, improved RT orientation, and establishment of a core staffing model, was associated with increased respiratory resource utilization and evidence-based practice, specifically BALs and SBTs.

Entities:  

Mesh:

Year:  2013        PMID: 22782139     DOI: 10.4187/respcare.01562

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  6 in total

1.  Blood alcohol content, injury severity, and adult respiratory distress syndrome.

Authors:  Majid Afshar; Gordon S Smith; Michael L Terrin; Matthew Barrett; Matthew E Lissauer; Sahar Mansoor; Jean Jeudy; Giora Netzer
Journal:  J Trauma Acute Care Surg       Date:  2014-06       Impact factor: 3.313

2.  Changes in transfusion practice over time in the PICU.

Authors:  Michael D Dallman; Xinggang Liu; Anthony D Harris; John R Hess; Bennett B Edelman; David J Murphy; Giora Netzer
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

3.  Trauma indices for prediction of acute respiratory distress syndrome.

Authors:  Majid Afshar; Gordon S Smith; Richard S Cooper; Sarah Murthi; Giora Netzer
Journal:  J Surg Res       Date:  2015-11-30       Impact factor: 2.192

4.  Training and Deployment of Medical Students as Respiratory Therapist Extenders during COVID-19.

Authors:  Thomas B Hester; Julia D Cartwright; Domenic G DiGiovine; Kevin J Karlic; Jacquelyn B Kercheval; Bruno DiGiovine; Steven E Gay; Carl Haas; Daphne Hawkins; Andrew Weirauch; Theodore J Iwashyna
Journal:  ATS Sch       Date:  2020-05-29

5.  To: Out-of-bed extubation: a feasibility study.

Authors:  Amanda Soares Skueresky; Soraia Genebra Ibrahim Forgiarini; Luiz Alberto Forgiarini Júnior; Alexandre Simões Dias
Journal:  Rev Bras Ter Intensiva       Date:  2015 Jul-Sep

6.  Effectiveness of the ABCDEF bundle on delirium, functional outcomes and quality of life in intensive care patients: a study protocol for a randomised controlled trial with embedded process evaluation.

Authors:  Kellie Sosnowski; Marion Mitchell; Marie Cooke; Hayden White; Lynette Morrison; Frances Lin
Journal:  BMJ Open       Date:  2021-07-15       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.